NCT02623803View on ClinicalTrials.gov

Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Pancreatectomy
Interventions
DRUG

Lidocaine

DRUG

Placebo D5W

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02623803 - Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies | Biotech Hunter | Biotech Hunter